Vaccines for Workers: Immune Aspects of Occupational Health

Abstract

With the rapid pace of immunologic research, it is more important than ever for readers to understand rational immunodiagnosis, immunoprophylaxis, and immunotherapy. This column is intended to help you carry out proper immuno-logic drug use in your practice.

Get full access to this article

View all access options for this article.

References

Grabenstein

J.D.

How to interpret immunization schedules and records. Hosp Pharm. 1999; 34: 482–6,489–91.

Grabenstein

J.D.

Targeting vaccines to specific clusters of people. Hosp Pharm. 1999; 34: 238–45.

Advisory Committee on Immunization Practices. Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures. Mor Mortal Wkly Rep CDC Surveill Summ. 1991; 40(RR-10):1–28.

Advisory Committee on Immunization Practices. General recommendations on immunization. Mor Mortal Wkly Rep CDC Surveill Summ. 1994; 43(RR-1):1–38.

Centers for Disease Control and Prevention. Shortage of tetanus and diphtheria toxoids. Mor Mortal Wkly Rep CDC Surveill Summ. 2000; 49: 1029–30.

Grabenstein

J.D.

Immunization Delivery: A Complete Guide. Saint Louis, MO: Facts and Comparisons, Inc.; 1997.

Grabenstein

J.D.

ImmunoFacts: Vaccines and Immunologic Drugs. 22nd rev. Saint Louis, MO: Facts and Comparisons, Inc.; May 2001.

Centers for Disease Control and Prevention. Health Information for International Travel, 2001-02. Washington, DC: Government Printing Office; 2001.

Advisory Committee on Immunization Practices. Human rabies prevention–United States, 1999. Mor Mortal Wkly Rep CDC Surveill Summ. 1999;48(RR-1):1–21. Erratum: 1998;48:16.

10.

Grabenstein

J.D.

High expectations: Standards and guidelines for immunization delivery. Hosp Pharm. 2000; 35: 841–51.

11.

Grabenstein

J.D.

Get it in writing: Documenting immunizations. Hosp Pharm. 1991; 26: 901–4.

12.

Grabenstein

J.D.

, Proulx

S.M.

, Cohen

M.R.

Recognizing and preventing errors with immunologic drugs. Hosp Pharm. 1996; 31: 791–4,799,803–4.

13.

Grabenstein

J.D.

, Kendal

A.P.

, Snyder

R.H.

Storing, handling, and shipping immunologic drugs. Hosp Pharm. 1996; 31: 936–8, 943-4,947–8.

14.

Grabenstein

J.D.

Anaphylaxis: Epinephrine and emergency responses. Hosp Pharm. 1997; 32: 1377–8,1382–4,1387–9.

15.

29 CFR § 1910.1030(f). www.oshaslc.gov/OshStd_data/1910_1030.html.

16.

Advisory Committee on Immunization Practices. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Mor Mortal Wkly Rep CDC Sur-veill Summ. 1991; 40(RR-13):1–19.

17.

ACIP. Immunization of health care workers. Mor Mortal Wkly Rep CDC Surveill Summ. 1997; 46(RR-18):1–42.

18.

Centers for Disease Control and Prevention. Guideline for infection control in health care personnel. Am J Infect Control. 1998; 26:289–354. Infect Control Hosp Epidemiol. 1998;19:407–63.

19.

Mahoney

F.J.

, Stewart

, Hu

Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997; 157: 2601–5.

20.

Wood

, Nguyen

V.H.

, Schmidt

Economic evaluations of influenza vaccination in healthy working-age adults. Pharmacoeconomics. 2000; 18: 173–83.

21.

Advisory Committee on Immunization Practices. Prevention and control of influenza. Mor Mortal Wkly Rep CDC Surveill Summ. 2000; 49(RR-3):1–38.

22.

Yeager

C.F.

The value of influenza virus vaccination in industry. Am J Public Health. 1952; 42: 723–5.

23.

Nichol

K.L.

, Lind

, Margolis

K.L.

The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995; 333: 889–93.

24.

Nichol

G.L.

, Mendelman

P.M.

, Mallon

K.P.

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: A randomized controlled trial. JAMA. 1999; 282: 137–44.

25.

Wilde

J.A.

, McMillan

J.A.

, Serwint

Effectiveness of influenza vaccine in health care professionals: A randomized trial. JAMA. 1999; 281: 908–13.

26.

Campbell

D.S.

, Rumley

M.H.

Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occupat Environ Med. 1997; 39: 408–14.

27.

Bridges

C.B.

, Thompson

W.W.

, Meltzer

M.I.

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000; 284: 1655–63.

28.

Murray

D.L.

Vaccine-preventable diseases and medical personnel: Ensure the immunity of all! [editorial]

Arch Intern Med. 1990; 150:25–6.

29.

Potter

, Stott

D.J.

, Roberts

M.A.

Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997; 175: 1–6.

30.

Carman

W.F.

, Elder

A.G.

, Wallace

L.A.

Effects of influenza vaccination of health care workers on mortality of elderly people in long-term care: A randomized controlled trial. Lancet. 2000; 355: 93–97.

31.

Grabenstein

J.D.

Pandemic influenza: Planning now to avoid another tragedy. Hosp Pharm. 1999; 34: 845–6,849–51, 855–6.

32.

Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States: Updated recommendations. MMWR. 2000; 49(RR-5):1–22.

33.

Advisory Committee on Immunization Practices. Prevention of hepatitis A through active or passive immunization. MMWR. 1999; 48(RR-12):1–37.

34.

Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. MMWR. 2000; 49(RR-15):1–20.

35.

Friedlander

A.M.

, Pittman

P.R.

, Parker

G.W.

Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax. JAMA. 1999; 282: 2104–6.

36.

Takafuji

E.T.

, Russell

P.K.

Military immunizations: Past, present, and future prospects. Infect Dis Clin N Amer. 1990; 4: 143–58.

37.

Meltzer

M.I.

, Shapiro

C.N.

, Mast

E.E.

The economics of vaccinating restaurant workers against hepatitis A. Vaccine. 2001; 19: 2138–45.

38.

Advisory Committee on Immunization Practices. Recommendations for the use of Lyme disease vaccine. MMWR. 1999; 48(RR-7):1–17, errata 833.

39.

Advisory Committee on Immunization Practices. Prevention and control of meningo-coccal disease and meningococcal disease and college students. MMWR. 2000; 49(RR-5):1–20.

40.

Grabenstein

J.D.

Vaccines and antibodies in relation to pregnancy and lactation. Hosp Pharm. 1999; 34: 949–52,955–6,959–60.